Concepedia

Publication | Closed Access

Pharmacogenetic Profiling for Cetuximab Plus Irinotecan Therapy in Patients With Refractory Advanced Colorectal Cancer

137

Citations

46

References

2008

Year

Abstract

Although additional studies are required for confirmation, our findings could optimize the use of cetuximab in MCRC patients.

References

YearCitations

Page 1